Treatment of Antiphospholipid Antibody Syndrome (APS) in Pregnancy: A Randomized Pilot Trial Comparing Low Molecular Weight Heparin to Unfractionated Heparin

Journal of Obstetrics and Gynaecology Canada

Volumn 26, Issue 8, 2004, Pages 729-734

  Stephenson, Mary D ^a,b   Ballem, Penny J ^a   Tsang, Peter ^a   Purkiss, Sue ^a,b   Ensworth, Stephanie ^a,b   Houlihan, Edwina ^b   Ensom, Mary H H ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Antiphospholipid syndrome; Dalteparin; Heparin; Heparin, low molecular weight; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; DALTEPARIN; HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; ANTICOAGULANT AGENT;

ADULT; ANTIPHOSPHOLIPID ANTIBODY SYNDROME; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG EFFICACY; EPIDURAL ANESTHESIA; FEMALE; GESTATIONAL AGE; HUMAN; LUTEAL PHASE; MATERNAL HYPERTENSION; OUTCOME ASSESSMENT; PILOT STUDY; PREGNANCY OUTCOME; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SPINAL ANESTHESIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MATERNAL CARE; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; DALTEPARIN; FEMALE; HEPARIN; HUMANS; PILOT PROJECTS; PRECONCEPTION CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 7944225659     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30644-2     Document Type: Article

References (28)

1. Ensom MHH, Stephenson MD Low-molecular-weight heparins in pregnancy. Pharmacotherapy 1999, 19:1013-1025.
2. Chamley LW, McKay EJ, Pattison NS Inhibition of heparin/antithrombin III cofiactor activity by anticardiolipin antibodies: a mechanism for thrombosis. Thromb Res 1993, 71:103-111.
3. Ermel LD, Marshburn PB, Kutteh WH Interaction of heparin with antiphospholipid antibodies (APA) from the sera of women with recurrent pregnancy loss (RPL). Am J Reprod Immunol 1995, 33:14-20.
4. Franklin RD, Kutteh WH Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro. Obstet Gynecol 2003, 101:455-462.
5. Hirsh J, Warkentin TE, Raschke R, Granger C, Ohman EM, Dalen JE Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest 1998, 114:489S-510S.
6. Backos M, Rai R, Baxter N, Chilcott IT, Cohen H, Regan L Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol 1999, 106:102-107.
7. Lockwood CJ, Rand JH The immunobiology and obstetrical consequences of antiphospholipid antibodies. Obstet Gynecol Surv 1994, 49:432-441.
8. Rai RS, Clifford K, Cohen H, Regan L High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod 1995, 10:3301-3304.
9. Kutteh WH Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996, 174:1584-1589.
10. Rai R, Cohen H, Dave M, Regan L Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997, 314:253-257.
11. Gillis S, Shushan A, Eldor A Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy. Int J Gynaecol Obstet 1992, 39:297-301.
12. Melissari E, Parker CJ, Wilson NV, Monte G, Kanthou C, Pemberton KD, et al. Use of low molecular weight heparin in pregnancy. Thromb Haemost 1992, 68:652-656.
13. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999, 42:1309-1311.
14. Harris EN The Second International Anticardiolipin Standardisation Workshop/The Kingston Antiphospholipid Antibody Study (KAPS) Group. Am J Pathol 1990, 94:476-484.
15. Kutteh WH, Wester R, Kutteh CC Multiples of the median: an alternative method for reporting antiphospholipid antibodies in women with recurrent pregnancy loss. Obstet Gynecol 1994, 84:811-815.
16. Brandt JT, Triplett DA, Alving B, Scharrer I Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995, 74:1185-1190.
17. Stephenson MD Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996, 66:24-29.
18. Adler RR, Ng AK, Rote NS Monoclonal antiphosphatidylserine antibody inhibits intercellular fusion of the choriocarcinoma line, JAR. Biol Reprod 1995, 53:905-910.
19. Katsuragawa H, Kanzaki H, Inoue T, Hirano T, Mori T, Rote NS Monoclonal antibody against phosphatidylserine inhibits in vitro human trophoblastic hormone production and invasion. Biol Reprod 1997, 56:50-58.
20. Antiphospholipid syndrome. ACOG Educational Bulletin 1998, 244:151-158. American College of Obstetricians and Gynecologists.
21. Bell KA, Van Deerlin PG, Haddad BR, Feinberg RF Cytogenetic diagnosis of "normal 46,XX" karyotypes in spontaneous abortions frequently may be misleading. Fertil Steril 1999, 71:334-341.
22. Fortuny A, Carrio A, Soler A, Cararach J, Fuster J, Salami C Detection of balanced chromosome rearrangements in 445 couples with repeated abortion and cytogenetic prenatal testing in carriers. Fertil Steril 1988, 49:774-779.
23. Jacobs PA, Hassold T Chromosome abnormalities: origin and etiology in abortions and livebirths. Human genetics 1987, 233-244. Springer-Verlag, Berlin. F. Vogal, K. Sperling (Eds.).
24. Farquharson RG, Quenby S, Greaves M Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002, 100:408-413.
25. Nelson-Piercy C, Letsky EA, de Swiet M Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol 1997, 176:1062-1068.
26. Kutteh WH Antiphospholipid syndrome in pregnancy: a randomized controlled trial of treatment [comment]. Obstet Gynecol 2002, 100:1354-1355.
27. Rai R, Regan L Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment [comment]. Obstet Gynecol 2002, 100:1354.
28. Aboulghar H, Aboulghar M, Mansour R, Serour G, Amin Y, Al Inany H A prospective controlled study of karyotyping for 430 consecutive babies conceived through intracytoplasmic sperm injection. Fertil Steril 2001, 76:249-253.